Home / Inspections / 1224917

FDA Inspection 1224917 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3004664162

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on November 6, 2023 in Hikari. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hikari (Japan)

Facility

Other inspections at this facility

  • 1148832 (VAI Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1111495 (OAI Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1033814 (NAI Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 951603 (VAI Fri Oct 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851370 (VAI Wed Sep 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources